@misc{indiciae6a01df6fb5a4,
  title = {Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations},
  author = {Choudhary, G. and Pellagatti, A. and Agianian, B. and Smith, M. and Bhagat, T. D. and Gordon-Mitchell, S. and Pandey, S. and Shah, N. and Aluri, S. and Schwartz, L. and Steeples, V. and Booher, R. and Ramachandra, M. and Samson, M. and Carbajal, M. and Pradhan, K. and Bowman, T. and Pillai, M. M. and Will, B. and Wickrema, A. and Shastri, A. and Bradley, R. K. and Martell, R. E. and Steidl, U. and Gavathiotis, E. and Boultwood, J. and Starczynowski, D. T. and Verma, A.},
  year = {2022},
  doi = {10.1101/2022.03.09.483595},
  url = {https://www.biorxiv.org/content/10.1101/2022.03.09.483595v1},
  note = {Source identifier: 10.1101/2022.03.09.483595}
}